Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

Novavax's vaccine has been available since 2022 in the U.S. after the FDA granted its emergency use. "We look forward to ...

Shares of Novavax Inc. (NVAX) traded 20% higher on Wednesday morning after the company expressed optimism about receiving ...

On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...

Novavax on Wednesday said the U.S. Food and Drug Administration has asked the company to commit to produce more data on its ...

The shingles vaccine reduced dementia risk by 20 percent in a recent study. The vaccine’s protective effect against dementia was more pronounced in women. Shingles vaccination is recommended for ...

Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine skeptic, said in an interview Tuesday that he encourages people to get vaccinated against measles after an outbreak has killed ...

Just last week, the US Food and Drug Administration delayed a decision on full approval of Novavax’s Covid-19 vaccine even though it was on track to be cleared, leaving many public health ...